 <h1>Sucralfate Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to sucralfate: oral suspension, oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, sucralfate may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking sucralfate:</p><p>
<i>Incidence not known</i>
</p><ul>
<li>Blue lips and fingernails</li>
<li>blurred vision</li>
<li>chest pain</li>
<li>cough</li>
<li>coughing that sometimes produces a pink frothy sputum</li>
<li>difficult, fast, noisy breathing</li>
<li>difficulty in swallowing</li>
<li>dry mouth</li>
<li>feeling of fullness</li>
<li>flushed, dry skin</li>
<li>fruit-like breath odor</li>
<li>hoarseness</li>
<li>increased hunger</li>
<li>increased sweating</li>
<li>increased thirst</li>
<li>increased urination</li>
<li>loss of appetite</li>
<li>nausea</li>
<li>pale skin</li>
<li>slow or irregular breathing</li>
<li>stomach pain</li>
<li>sweating</li>
<li>swelling of the face, mouth, lips, or throat</li>
<li>swelling of the legs and ankles</li>
<li>tightness in the chest</li>
<li>troubled breathing</li>
<li>unexplained weight loss</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of sucralfate may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Constipation</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Back ache</li>
<li>bloated</li>
<li>constipation</li>
<li>diarrhea</li>
<li>dizziness or lightheadedness</li>
<li>excess air or gas in the stomach or intestines</li>
<li>feeling of constant movement of self or surroundings</li>
<li>headache</li>
<li>hives, itching, skin rash</li>
<li>indigestion</li>
<li>passing gas</li>
<li>sensation of spinning</li>
<li>sleepiness</li>
<li>stomach cramps</li>
<li>trouble sleeping</li>
</ul><p>
<!-- end oral suspension, oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to sucralfate: compounding powder, oral suspension, oral tablet</i></p><h3>General</h3><p>The most commonly reported side effect was constipation.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation</p>
<p><b>Uncommon</b> (0.1% to 1%): Dry mouth, nausea</p>
<p><b>Rare</b> (0.01% to 0.1%): Bezoar formation</p>
<p><b>Frequency not reported</b>: Diarrhea, flatulence, gastric discomfort, indigestion, vomiting</p>
<p><b>Postmarketing reports</b>: Lip swelling, mouth edema<sup>[Ref]</sup></p><p>Bezoars were reported in patients with enteral feedings, delayed gastric emptying, and/or low birthweight neonates.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache</p>
<p><b>Frequency not reported</b>: Dizziness, drowsiness/sleepiness, encephalopathy, vertigo</p>
<p><b>Postmarketing reports</b>: Cerebral emboli<sup>[Ref]</sup></p><p>Encephalopathy occurred in patients with chronic renal impairment and/or on long-term treatment.</p>
<p></p>
<p>Cerebral emboli occurred in patients receiving IV administration.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Urticaria</p>
<p><b>Rare</b> (0.01% to 0.1%): Rash</p>
<p><b>Frequency not reported</b>: Pruritus</p>
<p><b>Postmarketing reports</b>: Face edema<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Osteodystrophy and osteomalacia occurred in patients with chronic renal impairment and/or on long-term treatment.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Back pain, osteodystrophy, osteomalacia<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Anaphylactic reaction, hypersensitivity reactions<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Dyspnea</p>
<p><b>Postmarketing reports</b>: Bronchospasm, laryngeal edema, pharyngeal edema, pulmonary emboli, respiratory tract edema<sup>[Ref]</sup></p><p>Pulmonary edema occurred after IV administration.<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Thirst</p>
<p><b>Postmarketing reports</b>: Face edema<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Anemia<sup>[Ref]</sup></p><p>Anemia occurred in patients with chronic renal impairment and/or on long-term treatment.<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Frequency not reported</b>: Insomnia<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Hyperglycemia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Edema<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Carafate (sucralfate)." Hoechst Marion-Roussel Inc, Kansas City, MO. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about sucralfate</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>167 Reviews</li>
<li>Drug class: miscellaneous GI agents</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Sucralfate &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Carafate</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +4 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>GERD</li>
<li>Duodenal Ulcer</li>
<li>Hyperphosphatemia of Renal Failure</li>
<li>Duodenal Ulcer Prophylaxis</li>
<li data-more-config-id="list-data-resources-conditions">... +3 more</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to sucralfate: compounding powder, oral suspension, oral tablet</i></p><h3>General</h3><p>The most commonly reported side effect was constipation.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation</p><p><b>Uncommon</b> (0.1% to 1%): Dry mouth, nausea</p><p><b>Rare</b> (0.01% to 0.1%): Bezoar formation</p><p><b>Frequency not reported</b>: Diarrhea, flatulence, gastric discomfort, indigestion, vomiting</p><p><b>Postmarketing reports</b>: Lip swelling, mouth edema<sup>[Ref]</sup></p><p>Bezoars were reported in patients with enteral feedings, delayed gastric emptying, and/or low birthweight neonates.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache</p><p><b>Frequency not reported</b>: Dizziness, drowsiness/sleepiness, encephalopathy, vertigo</p><p><b>Postmarketing reports</b>: Cerebral emboli<sup>[Ref]</sup></p><p>Encephalopathy occurred in patients with chronic renal impairment and/or on long-term treatment.</p><p></p><p>Cerebral emboli occurred in patients receiving IV administration.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Urticaria</p><p><b>Rare</b> (0.01% to 0.1%): Rash</p><p><b>Frequency not reported</b>: Pruritus</p><p><b>Postmarketing reports</b>: Face edema<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Osteodystrophy and osteomalacia occurred in patients with chronic renal impairment and/or on long-term treatment.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Back pain, osteodystrophy, osteomalacia<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Anaphylactic reaction, hypersensitivity reactions<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Dyspnea</p><p><b>Postmarketing reports</b>: Bronchospasm, laryngeal edema, pharyngeal edema, pulmonary emboli, respiratory tract edema<sup>[Ref]</sup></p><p>Pulmonary edema occurred after IV administration.<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Thirst</p><p><b>Postmarketing reports</b>: Face edema<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Anemia<sup>[Ref]</sup></p><p>Anemia occurred in patients with chronic renal impairment and/or on long-term treatment.<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Frequency not reported</b>: Insomnia<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Hyperglycemia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Edema<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Carafate (sucralfate)." Hoechst Marion-Roussel Inc, Kansas City, MO. </p><h2>More about sucralfate</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>167 Reviews</li>
<li>Drug class: miscellaneous GI agents</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Sucralfate &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +4 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>GERD</li>
<li>Duodenal Ulcer</li>
<li>Hyperphosphatemia of Renal Failure</li>
<li>Duodenal Ulcer Prophylaxis</li>
<li data-more-config-id="list-data-resources-conditions">... +3 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>